Retina/Vitreous News

A task force of medical optometry educators is requesting input on the recently released consensus document, Modern Fundamentals of Diabetic Retinopathy Management in Optometry, as part of the second phase of a public health initiative.

Ora Inc. has collaborated with BlindCAN Film Festival to launch the Blind Canvas Project, which combines storytelling with artificial intelligence to create art celebrating the lives of individuals with visual impairment.

SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Cedric Francois, MD, PhD, CEO of Apellis Pharmaceuticals, previews 3-year data investigating long-term treatment of geographic atrophy with Syfovre.

SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Mohamed Genead, MD, CEO of Aviceda Therapeutics, discusses a trial investigating AVD-104 for geographic atrophy secondary to age-related macular degeneration.

RetinalGeniX Technologies announced that it submitted patent applications for investigational drug candidates RTG-2023 and RTG-2024, for age-related macular degeneration and Alzheimer’s, respectively.

According to Prevent Blindness, more than 26% of people with diabetes have diabetic retinopathy, the most common diabetes-related eye disease and the primary cause of blindness in adults aged 20 to 74 years.

NEW ORLEANS — Electroretinograms can help predict progression of diabetic retinopathy, age-related macular degeneration and glaucoma by providing objective information about visual function, according to Nate Lighthizer, OD, at Academy ’23.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Marco A. Zarbin, MD, PhD, FACS, discusses a post hoc analysis of faricimab vs. aflibercept in patients with DME and visual acuity of 20/50 or worse.

SAN FRANCISCO — In this Healio Video Perspective from Retina Subspecialty Day at the AAO meeting, Arshad Khanani, MD, MA, FASRS, discusses 2-year results of the GATHER2 trial investigating avacincaptad pegol for geographic atrophy.

SAN FRANCISCO — An eye drop improved visual acuity in patients with diabetic macular edema, according to a study presented at Retina Subspecialty Day at the American Academy of Ophthalmology meeting.